The global psoriatic arthritis treatment market size is anticipated to touch USD 13.12 billion by the end of 2027 on account of the increasing prevalence of psoriatic arthritis. According to a published report by Fortune Business Insights titled, “Psoriatic Arthritis Treatment Market Size, Share & Industry Analysis, By Drugs Class (Non-steroidal Anti-inflammatory Drugs (NSAIDS), Non-biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs), Biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs) and Others), By Route of Administration (Oral, Parenteral, and Topical), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Regional Forecast, 2020-2027,” the value of this market was USD 6.35 billion in the year 2019. The forecast period is set between 2020 and 2027 and the market is expected to rise at a CAGR of 9.5%.
For More Information in the Analysis of Reports: https://www.fortunebusinessinsights.com/industry-reports/psoriatic-arthritis-treatment-market-101066
List of Companies Profiled in the Report:
- Bayer AG
- Bristol-Myers Squibb Company
- AstraZeneca
- Johnson & Johnson Services, Inc.
- Pfizer Inc.
- Eli Lilly and Company
- Novartis AG
- GlaxoSmithKline plc.
- Hoffmann-La Roche Ltd
- Amgen
- Sanofi
- Others
Rising Adoption of Biological Therapies to help North America Continue Dominating Market
Among all regions, North America accounted for the largest share on account of the massive investments in research and development of therapeutic options and coupled with the increasing adoption of biological therapies to treat psoriasis arthritis. Moreover, the presence of large manufacturers and the continuous number of clinical trials and drug approvals by the U.S. Food and Drug Administration will further help this region dominate the market in the coming years. Europe ranks second in terms of market size whereas Asia Pacific market is likely to emerge as the fastest growing region in the forecast duration on account of the improving healthcare infrastructure, rise in medical expenditure, and the entry of novel biologics.
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/psoriatic-arthritis-treatment-market-101066
Rising Prevalence of Psoriasis Arthritis to Augment Growth
The growing geriatric population and the increasing prevalence of psoriatic arthritis are the key factors boosting the global psoriatic arthritis treatment market growth. This disease is likely to prevail in people leading a stressful lifestyle. This, coupled with the increasing affordability of biologic products and new product launches, will also contribute positively to the growth of the market. On the negative side, the impact of the COVID-19 pandemic has reduced the urgency of other diseases and therefore hampered the growth of the market for psoriatic arthritis. Moreover, the high cost of biologic products used for treating this kind of disease may pose a major challenge to the growth of this market.
Major Table of Content for Psoriatic Arthritis Treatment Market:
- Introduction
- Research Scope
- Market Segmentation
- Research Methodology
- Definitions and Assumptions
- Executive Summary
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
- Key Insights
- Prevalence of Psoriatic Arthritis for Key Countries/Region
- Recent Industry Developments Such as Partnerships, Mergers & Acquisitions, New Product Launches Etc.
- Pipeline Analysis for Key Companies
- Regulatory Framework by Key Countries
- Impact of COVID-19 on Psoriatic Arthritis Treatment Market
- Global Psoriatic Arthritis Treatment Market Analysis, Insights and Forecast, 2016-2027
- Key Findings / Summary
- Market Analysis, Insights and Forecast – By Drug Class
- Non-steroidal Anti-inflammatory Drugs (NSAIDS)
- Non-biologic Disease Modifying Anti-Rheumatic Drugs
- Biologic Disease Modifying Anti-Rheumatic Drugs
- Market Analysis, Insights and Forecast – By Route of Administration
- Oral
- Parenteral
- Topical
- Market Analysis, Insights and Forecast – By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Market Analysis, Insights and Forecast – By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
TOC Continued…
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/psoriatic-arthritis-treatment-market-101066
Related Reports:
About Us
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights™, we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand current competitive challenges.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune – 411045, Maharashtra, India.
Phone:
US:+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245